CAG
QGENF

Crestwood Advisors Group’s QIAGEN NV QGENF Stock Holding History

Crestwood Advisors Group’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7,300
Closed -$202K – 160
2015
Q4 		$202K Buy
+7,300
New +$202K 0.02% 144

Other funds holding QGENF

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Crestwood Advisors Group's QGENF Position: Q1 2016 in Review

Crestwood Advisors Group sold out of QIAGEN NV (QGENF) in Q1 2016, closing a stake of 7,300 shares — an estimated $202K sold.

Crestwood Advisors Group first reported a position in QGENF in Q4 2015 and held it in 1 quarter. The position peaked at $202K in Q4 2015. 201 funds tracked by Wall St. Rank hold QGENF as of Q1 2016.

  • Crestwood Advisors Group reported no remaining QIAGEN NV position as of Q1 2016 after selling out during the quarter.
  • Crestwood Advisors Group sold 7,300 QIAGEN NV shares in Q1 2016, an estimated $202K.
  • Crestwood Advisors Group first reported a position in QIAGEN NV in Q4 2015 and held it in 1 quarter.
  • Crestwood Advisors Group's QIAGEN NV position peaked at $202K in Q4 2015.
  • 201 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2016.

Based on Crestwood Advisors Group's 13F filing for Q1 2016, filed 16 May 2016.